• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Rate shock now less shocking


The 21 to 27 age group will see net costs increase $470, and that's the worst of it

Subsidies and access to employer-sponsored insurance and Medicaid will help shield the population that is expected to experience “rate shock” when the mandatory 3-to-1 age rating bands go into effect, according to analysis by the Urban Institute. Current age rating ratios can typically be 5-to-1 or greater.

Using a simulation model, the organization was able to illustrate modest impact on out-of-pocket outlays for younger nongroup purchasers once subsidies and other protections were figured in. The study notes that many enrollees in the health exchanges will be eligible for subsidies.

For example, 92% of those age 21 to 27 will have incomes below 300% of federal poverty level. Among those in this age group with current nongroup coverage, 67% would be eligible for Medicaid, CHIP or subsidies.

However, this age group is the most likely to see higher net costs under the  3-to-1 age rating bands. Net costs encompassing premiums, plus out-of-pocket, less subsidies, could increase from $5,350 in the 5-to-1 ratio to $5,820 in the  3-to-1 situation-a difference of an additional $470. Other age groups see less of a difference.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.